Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy. | Sci Rep | 2022 | 36460718 | PubTator, text mining | PubMed |
| Evolutionarily conserved gene expression patterns for affective disorders revealed using cross-species brain transcriptomic analyses in humans, rats and zebrafish. | Sci Rep | 2022 | 36460699 | PubTator, text mining | PubMed |
| Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36452497 | PubTator, text mining | PubMed |
| SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer. | Front Pharmacol | 2022 | 36438826 | PubTator, text mining | PubMed |
| The Predicted Splicing Variant c.11+5G>A in RPE65 Leads to a Reduction in mRNA Expression in a Cell-Specific Manner. | Cells | 2022 | 36429068 | PubTator, text mining | PubMed |
| Recombinant Turkey Herpesvirus Expressing H9N2 HA Gene at the HVT005/006 Site Induces Better Protection Than That at the HVT029/031 Site. | Viruses | 2022 | 36423104 | PubTator, text mining | PubMed |
| A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma. | Front Genet | 2022 | 36419832 | PubTator, text mining | PubMed |
| Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis. | Front Oncol | 2022 | 36408192 | PubTator, text mining | PubMed |
| A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer. | Front Oncol | 2022 | 36408135 | PubTator, text mining | PubMed |
| Precision Medicine Approach to Cochlear Implantation. | Clin Exp Otorhinolaryngol | 2022 | 36397263 | PubTator, text mining | PubMed |
| Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden. | Front Immunol | 2022 | 36389735 | PubTator, text mining | PubMed |
| Concurrent newborn hearing and genetic screening of common hearing loss variants with bloodspot-based targeted next generation sequencing in Jiangxi province. | Front Pediatr | 2022 | 36389375 | PubTator, text mining | PubMed |
| RNA-based therapies in inherited retinal diseases. | Ther Adv Ophthalmol | 2022 | 36388727 | PubTator, text mining | PubMed |
| Fusion gene recurrence in non-small cell lung cancers and its association with cigarette smoke exposure. | Transl Lung Cancer Res | 2022 | 36386463 | PubTator, text mining | PubMed |
| Case report: novel PCDH15 variant causes usher syndrome type 1F with congenital hearing loss and syndromic retinitis pigmentosa. | BMC Ophthalmol | 2022 | 36384460 | PubTator, text mining | PubMed |
| Construction and Validation of Early Warning Model of Lung Cancer Based on Machine Learning: A Retrospective Study. | Technol Cancer Res Treat | 2022 | 36380607 | PubTator, text mining | PubMed |
| A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice. | BMC Cancer | 2022 | 36376839 | PubTator, text mining | PubMed |
| Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology. | Pharmaceutics | 2022 | 36365206 | PubTator, text mining | PubMed |
| Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. | Int J Mol Sci | 2022 | 36362398 | PubTator, text mining | PubMed |
| Minigene-Based Splice Assays Reveal the Effect of Non-Canonical Splice Site Variants in USH2A. | Int J Mol Sci | 2022 | 36362125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=27